Organization
University of Jena
5 clinical trials
1 abstract
Abstract
Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial.Org: University Hospital of Regensburg, University Medicine Greifswald, Pediatric Hematology and Oncology, University Medical Center Dresden, University of Jena, University Children's Hospital,
Clinical trial
Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications in the Context of Total Hip ArthroplastyStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance TherapyStatus: Completed, Estimated PCD: 2022-05-31
Clinical trial
Frontline Asciminib Combination in Chronic Phase CMLStatus: Active (not recruiting), Estimated PCD: 2027-12-01
Clinical trial
Treatment Optimization for Patients With Chronic Myeloid Leukemia (CML) With Treatment naïve Disease (1st Line) and Patients With Resistance or Intolerance Against Alternative Abl-Kinase Inhibitors (≥2nd Line)Status: Completed, Estimated PCD: 2023-03-31